Valeant Stock Tumbles on $750 Million Debt Offering Announcement
In late October, the company announced it was on pace to exceed an earlier goal of paying down $5 billion in debt by February 2018.

Valeant Pharmaceuticals Int'l Inc. (VRX) shares dipped 1.63% to $15.13 in mid-morning trading Monday, Nov. 13, after the drug maker launched a $750 million debt offering.

Valeant announced the private offering with notes due in 2025 in a statement Monday. The proceeds from the offering of the existing 5.5% senior secured notes will be used to repay a portion of term loan facilities due in 2022, Valeant said.

In late October, the company announced it was on pace to exceed an earlier goal of paying down $5 billion in debt by February 2018. Valeant still has more than $26 billion in debt, but no obligations until 2020.

Valeant stock has gained 4.27% since the start of the year, compared to the broader S&P 500 Index's 15.3% gain in the same period.

More of What's Trending on TheStreet:

More from Stocks

Bank of America Rips on Earnings Beat, But Analysts See Even More Gains Ahead

Bank of America Rips on Earnings Beat, But Analysts See Even More Gains Ahead

3 Reasons Why Netflix Bulls Are Getting Their Face Ripped Off After Earnings

3 Reasons Why Netflix Bulls Are Getting Their Face Ripped Off After Earnings

Stocks End Mixed as Dow Rises, S&P 500 and Nasdaq Slip

Stocks End Mixed as Dow Rises, S&P 500 and Nasdaq Slip

Action Alerts Plus is Picking Raytheon Over Other Defense Names

Action Alerts Plus is Picking Raytheon Over Other Defense Names

Should Tesla Actually Fire Elon Musk?

Should Tesla Actually Fire Elon Musk?